# Universal Technical Institute Inc: Form 10-Q for the period ended Dec 31, 2023

- Company: [Universal Technical Institute Inc](/companies/uti.md) (CIK 1261654)
- Form: 10-Q
- Filed: 2024-02-08
- Accepted by EDGAR: Feb 8, 2024, 08:58 ET
- Period: 2023-12-31
- Accession: 0001261654-24-000011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1261654/000126165424000011/uti-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1261654/000126165424000011/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2023-10-01 to 2023-12-31 | $174.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months, 2023-10-01 to 2023-12-31 | $68.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2023-10-01 to 2023-12-31 | $14.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2023-10-01 to 2023-12-31 | $2.9m | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-10-01 to 2023-12-31 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-10-01 to 2023-12-31 | $10.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-10-01 to 2023-12-31 | $0.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-10-01 to 2023-12-31 | $0.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-10-01 to 2023-12-31 | 37,439,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2023-10-01 to 2023-12-31 | $10.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2023-10-01 to 2023-12-31 | $3.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2023-12-31 | $143.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | $197.4m | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $732.4m | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $181.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-12-31 | $510.2m | us-gaap:Liabilities |
| Long-term debt | at 2023-12-31 | $159.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2023-12-31 | $2.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-12-31 | $222.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 34,778 characters.

*The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and those in our 2023 Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under “Risk Factors” in our 2023 Annual Report on Form 10-K and included in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also “Cautionary Note Regarding Forward-Looking Statements” on page ii of this Quarterly Report on Form 10-Q.*

### Company Overview

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs.

***Universal Technical Institute (“UTI”):*** UTI operates 16 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology (“MIAT”). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

***Concorde Career Colleges (“Concorde”):*** Concorde operates across 17 campuses in eight states, offering degree, non-degree, and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. See Note 19 of the notes to the condensed consolidated financial statements herein for additional details on our segments.

All of our campuses are accredited and are eligible for federal student financial assistance funds under the Higher Education Act of 1965, as amended, commonly referred to as Title IV Programs, which are administered by the U.S. Department of Education. Our programs are also eligible for financial aid from federal sources other than Title IV Programs, such as the programs administered by the U.S. Department of Veterans Affairs and under the Workforce Innovation and Opportunity Act.

We believe that our industry-focused educational model and national presence has enabled us to develop valuable industry relationships, which provide us with significant competitive advantages and supports our market leadership, along with enabling us to provide highly specialized education to our students, resulting in enhanced employment opportunities and the potential for higher wages for our graduates.

### Overview of the Three Months Ended December 31, 2023

### Student Metrics

| UTI | Three Months Ended December 31,% 2023 | 2022(1) | Change |
| --- | ---: | ---: | ---: |
| Total new student starts | 2,314 | 1,974 | 17.2% |
| Average undergraduate full-time active students | 14,321 | 13,511 | 6.0% |
| End of period undergraduate full-time active students | 13,682 | 12,657 | 8.1% |
| **Concorde** |  |  |  |
| Total new student starts | 2,032 | 321 | 533.0% |
| Average undergraduate full-time active students | 8,244 | 7,737 | 6.6% |
| End of period undergraduate full-time active students | 8,150 | 7,630 | 6.8% |
| **Consolidated** |  |  |  |
| Total new student starts | 4,346 | 2,295 | 89.4% |
| Average undergraduate full-time active students | 22,565 | 21,248 | 6.2% |
| End of period undergraduate full-time active students | 21,832 | 20,287 | 7.6% |

(1) New student starts and average student data for Concorde presented in the three months ended December 31, 2022 column represents the period of UTI’s ownership, or December 1, 2022 through December 31, 2022.

For three months ended December 31, 2023, the increase in UTI new student starts was primarily due to the successful rollout of 13 new programs across eight campuses during the fiscal 2023 fourth quarter and increased student demand at a majority of the remaining UTI campuses. Concorde had a strong quarter with an increase in end of period students compared to the prior year. On a consolidated basis, the acquisition of Concorde increased our new student starts and our average and end of period undergraduate full-time active students.

Our ability to start new students can be influenced by various factors including: impacts of the state of the general macro-economic environment and its impact on price sensitivity and the ability and willingness of students and their families to incur debt to fund their education; unemployment rates; competition; adverse media coverage, legislative, or regulatory actions and investigations by attorneys general and various agencies related to allegations of wrongdoing on the part of other companies within the education and training services industry, which can cast the aggregate “for-profit” education industry in a negative light; and pandemics and or other national, state or local emergencies as declared by various government authorities.

### Operations

Revenues for the three months ended December 31, 2023 were $174.7 million, an increase of $54.7 million, or 45.6%, from the comparable period in the prior year. Concorde contributed $59.3 million of revenue during the three months ended December 31, 2023 compared to $14.4 million during the one month ended December 31, 2022. UTI revenues increased by approximately $9.8 million, or 9.2%, driven by the higher starts and average students previously noted.

Total income from operations was $14.2 million during the three months ended December 31, 2023, compared to $4.4 million for the three months ended December 31, 2022. The increase in our income from operations was primarily driven by a full quarter of Concorde operations in fiscal year 2024 and the increased UTI revenue. Additionally, productivity improvements and proactive cost actions have been a key part of our operating model for the past several years, and we continue to identify and execute on efficiency opportunities throughout our cost structure.

### Business Strategy

Our business strategy has three key tenets: (i) to grow the business by more deeply penetrating existing target markets and adding new markets; (ii) to diversify the business by adding new locations, programs, and offerings that maximize the lifetime value of our students; and (iii) to continually optimize the business by constantly enhancing operational efficiency.

During the three months ended December 31, 2023, we executed the following as part of our business strategy:

- Concorde announced the launch of additional program offerings in dental hygiene in Jacksonville, Florida and sonography in Orlando, Florida and San Bernardino, California. Two additional dental hygiene programs are planned to launch later in 2024, pending final regulatory approval.
- UTI announced additional program expansions of Heating Ventilation Air Conditioning and Refrigeration in Avondale, Arizona, Bloomfield, New Jersey, Long Beach, California and Sacramento, California. The programs are expected to launch in late fiscal 2024 and early fiscal 2025.
- UTI announced plans to consolidate our two Houston, Texas campuses to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus, acquired in November 2021, will begin operating under the UTI brand and implement a phased teach-out agreement starting in May 2024. Both facilities will remain in use post-consolidation. See Note 15 of the notes to our condensed consolidated financial statements herein for further details on the restructuring.

In addition, we continue to pursue other opportunities that align with our business strategy.

### Regulatory Environment

See Note 20 of the notes to our condensed consolidated financial statements herein for a discussion of our regulatory environment.

### Results of Operations: Three Months Ended December 31, 2023 Compared to Three Months Ended December 31, 2022

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated.

|  | Three Months Ended December 31, 2023 | 2022 |
| --- | ---: | ---: |
| Revenues | 100.0% | 100.0% |
| Operating expenses: |  |  |
| Educational services and facilities | 52.9% | 51.2% |
| Selling, general and administrative | 39.0% | 45.1% |
| Total operating expenses | 91.9% | 96.3% |
| Income from operations | 8.1% | 3.7% |
| Interest income | 1.1% | 0.7% |
| Interest expense | (1.6)% | (1.2)% |
| Other income (expense), net | 0.1% | 0.3% |
| Total other expense, net | (0.4)% | (0.2)% |
| Income before income taxes | 7.8% | 3.5% |
| Income tax expense | (1.8)% | (1.3)% |
| Net income | 5.9% | 2.2% |
| Preferred stock dividends | (0.6)% | (1.1)% |
| Income available for distribution | 5.3% | 1.1% |
| Income allocated to participating securities | (1.6)% | (0.4)% |
| Net income available to common shareholders | 3.7% | 0.7% |

26

### Revenues

The following table presents revenue by segment (in thousands):

|  | Three Months Ended December 31, 2023 UTI | Concorde | Consolidated | Three Months Ended December 31, 2022 UTI | Concorde | Consolidated |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $115,373 | $59,322 | $174,695 | $105,573 | $14,431 | $120,004 |
| Year over Year % Change | 9.3% | 311.1% | 45.6% |  |  |  |

Revenues for the three months ended December 31, 2023 were $174.7 million, an increase of $54.7 million, or 45.6%, as compared to revenues of $120.0 million for the three months ended December 31, 2022.

#### UTI

Revenues for UTI for the three months ended December 31, 2023 were $115.4 million. Revenue increased primarily due to a 6.0% increase in average students during the quarter and 17.2% increase in student starts from the prior year.

#### Concorde

Revenues for Concorde for the three months ended December 31, 2023 were $59.3 million compared to $14.4 million. The increase is primarily due to a full quarter of Concorde operations in fiscal year 2024 compared to only a month in the prior year. During the quarter, we had student starts of 2,032 and average students increased 6.6% from the prior year.

### Educational services and facilities expenses

Educational services and facilities expenses were $92.4 million for the three months ended December 31, 2023, which represents an increase of $31.0 million as compared to $61.4 million for the three months ended December 31, 2022, which is primarily due to the acquisition of Concorde on December 1, 2022 and both ongoing and one-time costs associated with our business strategies.

The following tables set forth the significant components of our educational services and facilities expenses by segment (in thousands):

|  | Three Months Ended December 31, 2023 UTI | Concorde | Consolidated |
| --- | ---: | ---: | ---: |
| Salaries, employee benefits and tax expense | $26,902 | $21,826 | $48,728 |
| Bonus expense | 653 | 137 | 790 |
| Stock-based compensation | 87 | — | 87 |
| Compensation and related costs | 27,642 | 21,963 | 49,605 |
| Occupancy costs | 7,458 | 5,563 | 13,021 |
| Supplies, maintenance and student expense | 10,413 | 3,861 | 14,274 |
| Depreciation and amortization expense | 5,392 | 1,258 | 6,650 |
| Contract services expense | 884 | 503 | 1,387 |
| Other educational services and facilities expense | 5,579 | 1,893 | 7,472 |
| Total educational services and facilities expense | $57,368 | $35,041 | $92,409 |

27

|  | Three Months Ended December 31, 2022 UTI | Concorde | Consolidated |
| --- | ---: | ---: | ---: |
| Salaries, employee benefits and tax expense | $26,852 | $6,559 | $33,411 |
| Bonus expense | 656 | — | 656 |
| Stock-based compensation | 81 | — | 81 |
| Compensation and related costs | 27,589 | 6,559 | 34,148 |
| Occupancy costs | 7,682 | 1,764 | 9,446 |
| Supplies, maintenance and student expense | 4,585 | 911 | 5,496 |
| Depreciation and amortization expense | 4,417 | 420 | 4,837 |
| Contract services expense | 1,065 | 56 | 1,121 |
| Other educational services and facilities expense | 5,539 | 821 | 6,360 |
| Total educational services and facilities expense | $50,877 | $10,531 | $61,408 |

#### UTI

Compensation and related costs remained roughly flat for the three months ended December 31, 2023.

Supplies, maintenance and student expense increased by $5.8 million primarily due to the increased cost of student housing of $5.3 million in support of relocating students.

Depreciation expense increased by $1.0 million for the three months ended December 31, 2023 primarily due to purchasing the three primary buildings at the Orlando, Florida campus along with the capital expenditures related to construction and new equipment costs for the Austin, Texas and Miramar, Florida campuses, and the thirteen program expansions that occurred during fiscal 2023.

### Selling, general and administrative expenses

Selling, general and administrative expenses for the three months ended December 31, 2023 were $68.1 million. This represents an increase of $13.9 million, as compared to $54.1 million for the three months ended December 31, 2022, which is primarily due to the acquisition of Concorde on December 1, 2022 and both ongoing and one-time costs associated with our business strategies.

During fiscal 2023, in coordination with the integration of Concorde, we began to reassess our operating model to determine the organizational structure that would best help the Company achieve future growth goals and optimally support the business. Beginning in fiscal 2024, we have executed an internal reorganization to fully transition our operating and reporting model to support a multi-divisional business. As part of the internal reorganization, each of the reportable segments now have dedicated accounting, finance, information technology, and human resources teams. Additionally, human resources and information technology costs that benefit the entire organization are now allocated across UTI, Concorde and Corporate each period based upon relative headcount. As a result, additional costs have moved from Corporate into the UTI segment and to a lesser extent the Concorde segment as resources were redirected to support the segment’s objectives. Due to these changes in allocation methodology, the prior year amounts for selling, general and administrative expenses have been recast for comparability to the current year presentation.

The following tables set forth the significant components of our selling, general and administrative expenses by segment (in thousands):

|  | Three Months Ended December 31, 2023 UTI | Concorde | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Salaries, employee benefits and tax expense | $18,465 | $6,366 | $3,563 | $28,394 |
| Bonus expense | 2,841 | 720 | 1,022 | 4,583 |
| Stock-based compensation | 383 | 8 | 1,003 | 1,394 |
| Compensation and related costs | 21,689 | 7,094 | 5,588 | 34,371 |
| Advertising and marketing expense | 13,353 | 6,092 | — | 19,445 |
| Professional and contract services expense | 1,703 | 1,367 | 2,507 | 5,577 |
| Other selling, general and administrative expenses | 6,170 | 2,600 | (108) | 8,662 |
| Total selling, general and administrative expenses | $42,915 | $17,153 | $7,987 | $68,055 |

|  | Three Months Ended December 31, 2022 UTI | Concorde | Corporate | Consolidated |
| --- | ---: | ---: | ---: | ---: |
| Salaries, employee benefits and tax expense | $16,630 | $1,917 | $3,875 | $22,422 |
| Bonus expense | 2,887 | 188 | 1,134 | 4,209 |
| Stock-based compensation | 171 | — | 917 | 1,088 |
| Compensation and related costs | 19,688 | 2,105 | 5,926 | 27,719 |
| Advertising and marketing expense | 13,349 | 1,280 | — | 14,629 |
| Professional and contract services expense | 2,000 | 41 | 2,175 | 4,216 |
| Other selling, general and administrative expenses | 6,237 | 1,200 | 147 | 7,584 |
| Total selling, general and administrative expenses | $41,274 | $4,626 | $8,248 | $54,148 |

#### UTI

Compensation and related costs increased by $2.0 million for the three months ended December 31, 2023 primarily due to additional headcount hired to support the UTI segment.

Advertising and marketing expense remained flat year over year. UTI continues to target cost-efficient marketing with an increased focus on digital media. UTI advertising and marketing expense as a percentage of revenues decreased to 11.6% for the three months ended December 31, 2023 as compared to 12.6% in the prior year.

#### Concorde

Selling, general and administrative expenses for Concorde for the three months ended December 31, 2023 were $17.2 million. Concorde advertising and marketing expense as a percentage of revenues for the three months ended December 31, 2023 was 10.3%.

#### Corporate

Selling, general and administrative expenses for Corporate decreased slightly for the three months ended December 31, 2023 primarily due to a $0.3 million decrease in compensation related costs, partially offset by a $0.3 million increase in professional fees and contract services.

### Income taxes

Income tax expense for the three months ended December 31, 2023 was $3.2 million, or 23.3% of pre-tax income, compared to $1.5 million, or 36.5% of pre-tax income, for the three months ended December 31, 2022. The effective income tax rate for the three months ended December 31, 2023 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three months ended December 31, 2022 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, transaction costs and state and local income and franchise taxes. See Note 14 of the notes to the condensed consolidated financial statements herein for additional details.

### Preferred stock dividends

As of December 31, 2023, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares as of December 18, 2023. A final dividend payment of $1.1 million was paid to preferred shareholders of record as of December 18, 2023. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our Series A Preferred Stock.

As of September 30, 2023, 675,885 shares of Series A Convertible Preferred Stock were issued and outstanding. Pursuant to the Certificate of Designations of the Series A Preferred Stock (the “CoD”), we recorded a preferred stock cash dividend of $1.3 million for the three months ended December 31, 2022.

### Income available for distribution

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $9.3 million and $1.4 million for the three months ended December 31, 2023 and 2022, respectively.

### Income allocated to participating securities

Series A Preferred Stock is considered a participating security because, in the event that we pay a dividend or make a distribution on the outstanding common stock, we shall also pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. As such, the final amount of income allocated to participating securities is $2.9 million for the three months ended December 31, 2023. The income allocated to participating securities for the three months ended December 31, 2022 was $0.5 million.

### Net income available to common shareholders

We had $6.4 million and $0.9 million of net income available to common shareholders for the three months ended December 31, 2023 and 2022, respectively.

### Non-GAAP Financial Measures

Our earnings before interest income, income taxes, depreciation and amortization (“EBITDA”) for the three months ended December 31, 2023 and 2022 were $21.4 million and $10.0 million, respectively. We define EBITDA as net income, before interest (income) expense, income tax expense (benefit), and depreciation and amortization.

EBITDA is a non-GAAP financial measure which is provided to supplement, but not substitute for, the most directly comparable GAAP measure. We choose to disclose this non-GAAP financial measure because it provides an additional analytical tool to clarify our results from operations and helps to identify underlying trends. Additionally, this measure helps compare our performance on a consistent basis across time periods. Management also utilizes EBITDA as a performance measure internally. To obtain a complete understanding of our performance, this measure should be examined in connection with net income determined in accordance with GAAP. Since the items excluded from this measure should be examined in connection with net income in determining financial performance under GAAP, this measure should not be considered an alternative to net income as a measure of our operating performance or profitability. Exclusion of items in our non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure across companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

EBITDA reconciles to net income, as follows (in thousands):

|  | Three Months Ended December 31, 2023 | 2022 |
| --- | ---: | ---: |
| Net income | $10,389 | $2,648 |
| Interest income | (1,975) | (823) |
| Interest expense | 2,871 | 1,423 |
| Income tax expense | 3,160 | 1,525 |
| Depreciation and amortization | 6,984 | 5,248 |
| EBITDA | $21,429 | $10,021 |

### Liquidity and Capital Resources

### Overview of Liquidity

Based on past performance and current expectations, we believe that our cash flows from operations, cash on hand and investments will satisfy our working capital needs, capital expenditures, commitments and other liquidity requirements associated with our existing operations, as well as announced program expansions over the next 12 months and beyond. Our cash position is available to fund strategic long-term growth initiatives, including opening additional campuses in new markets and the creation and expansion of new programs, in existing markets where we continue to optimize utilization of our campus facilities.

Our aggregate cash and cash equivalents were $143.6 million as of December 31, 2023, a decrease of $8.0 million from September 30, 2023. We also had available liquidity under our revolving credit facility of $8.2 million, which was unchanged from September 30, 2023.

#### Strategic Uses of Cash

We believe that additional strategic uses of our cash resources may include consideration of additional strategic acquisitions and organic growth initiatives, the purchase of real estate assets, subsidizing funding alternatives for our students, and the repurchase of common stock, among others. To the extent that potential acquisitions are large enough to require financing beyond cash from operations, cash and cash equivalents, and short-term investments, or we need capital to fund operations, new campus openings or expansion of programs at existing campuses, we may enter into additional credit facilities, issue debt or issue additional equity.

#### Long-term Debt

As of December 31, 2023, we had $162.0 million of long-term debt outstanding, which is comprised of two term loans, a finance lease and a revolving credit facility. Of the $162.0 million outstanding, $29.0 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046% over the seven-year term secured in connection with the Avondale, Arizona campus property purchased in December 2020. Approximately $37.5 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% over the seven-year term, secured in connection with the Lisle, Illinois campus property. For each of the term loans, a derivative interest rate swap is in place that fixes the interest rate on 50% of the loan at a market rate at the time the derivative was initiated. Approximately $5.4 million relates to a finance lease for a campus within our Concorde segment. The remaining $90.0 million relates to funds drawn from the $100.0 million revolving credit facility that was secured in connection with the Concorde acquisition. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details on the term loans and the revolving credit facility.

#### Dividends

We currently do not pay a cash dividend on our common stock. A final cash dividend payment of $1.1 million was paid to Series A Preferred Stockholders of record as of December 18, 2023 during the three months ended December 31, 2023 as a result of the conversion of the Series A Preferred Stock. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our preferred stock.

#### Principal Sources of Liquidity

Our principal source of liquidity is operating cash flows and existing cash and cash equivalents. A majority of our revenues are derived from Title IV Programs and various veterans’ benefits programs. Federal regulations dictate the timing of disbursements of funds under Title IV Programs. Students must apply for new funding for each academic year consisting of 30-week periods. Loan funds are generally provided in two disbursements for each academic year. The first disbursement for first-time borrowers is usually received 30 days after the start of a student’s academic year, and the second disbursement is typically received at the beginning of the 16th week from the start of the student’s academic year. Under our UTI proprietary loan program, we bear all credit and collection risk and students are not required to begin repayment until six months after the student completes or withdraws from his or her program. Similarly, we bear all credit and collection risk for students paying through UTI cash payment plans and those under a retail installment contract at Concorde. These factors, together with the timing of when our students begin their programs, affect the timing and seasonality of our operating cash flow.

### Operating Activities

Our net cash provided by operating activities was $10.8 million for the three months ended December 31, 2023, compared to $2.8 million for the three months ended December 31, 2022.

Net income, after adjustments for non-cash items, for the three months ended December 31, 2023 provided cash of $25.0 million. The non-cash items included $7.0 million for depreciation and amortization expense, $5.5 million for amortization of right-of-use assets for operating leases, $1.5 million for stock-based compensation expense, and $1.5 million for bad debt expense.

Changes in operating assets and liabilities used cash of $14.2 million primarily due to the following:

- Changes in our operating lease liability, primarily as a result of rent payments, used cash of $4.7 million.
- The change in deferred revenue used cash of $4.3 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at December 31, 2023 as compared to September 30, 2023.
- The increase in prepaid expenses and notes receivable used cash of $4.1 million and $2.7 million, respectively, primarily due to the timing of payments.

Net income, after adjustments for non-cash items, for the three months ended December 31, 2022 provided cash of $14.4 million. The non-cash items included $4.1 million for amortization of right-of-use assets for operating leases, $5.2 million for depreciation and amortization expense and $1.2 million for stock-based compensation expense, and a change in deferred tax assets of $1.1 million.

Changes in operating assets and liabilities used cash of $11.6 million primarily due to the following:

- The decrease in accounts payable and accrued expenses used cash of $15.9 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.
- Changes in our operating lease liability, primarily as a result of rent payments, used cash of $5.0 million.
- The increase in deferred revenue provided cash of $4.6 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at December 31, 2022 as compared to September 30, 2022.
- The decrease in receivables provided cash of $4.7 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

### Investing Activities

During the three months ended December 31, 2023, cash used in investing activities was $3.8 million. The cash outflow was related to the purchase of property and equipment of $3.8 million.

During the three months ended December 31, 2022, cash provided by investing activities was $5.2 million. The cash inflow was due to proceeds from maturities of held-to-maturity securities of $29.0 million, offset by cash outflow related to the purchase of Concorde for $17.0 million, net of cash consideration received. Additionally, we purchased property and equipment of $6.8 million which primarily related to capital expenditures for our new campuses in Austin, Texas and Miramar, Florida, and the rollout of new programs at our other campuses.

### Financing Activities

During the three months ended December 31, 2023, cash used in financing activities was $15.1 million which was primarily related to the repurchase of Series A Preferred Stock of $11.3 million. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the repurchase. Additional uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $2.1 million, the payment of dividends of $1.1 million, and the repayment of long-term debt of $0.6 million.

During the three months ended December 31, 2022, cash provided by financing activities was $88.7 million which was primarily related to proceeds from our revolving credit facility of $90.0 million, offset by $0.5 million in payments of payroll taxes on stock-based compensation through shares withheld, debt issuance costs related to the revolving credit facility of $0.5 million and the repayment of long-term debt of $0.3 million.

### Seasonality and Trends

Our operating results normally fluctuate as a result of seasonal variations in our business, principally due to changes in total student population and costs associated with opening or expanding our campuses. Our student population varies as a result of new student enrollments, graduations and student attrition. Historically, UTI has had lower student populations in the third quarter than in the remainder of the year because fewer students are enrolled during the summer months. Additionally, UTI has had higher student populations in the fourth quarter than in the remainder of the year because more students enroll during this period. Concorde typically has higher student populations in January and August through October for its core programs and in February for its clinical programs. UTI and Concorde core program expenses do not vary significantly with changes in student population and revenues. Concorde clinical program expenses fluctuate based on the academic calendar and season due to the timing of clinical starts. We expect quarterly fluctuations in operating results to continue as a result of seasonal enrollment patterns. However, such patterns may change as a result of new school openings, new program introductions, increased enrollments of adult students or acquisitions.

### Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with GAAP and management’s discussion and analysis of our financial condition and operating results require management to make judgments, assumptions and estimates that affect the amounts reported. There were no significant changes in our critical accounting policies and estimates in the three months ended December 31, 2023 from those previously disclosed in Part II, Item 7 of our 2023 Annual Report on Form 10-K.

### Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, see Note 3 of the notes to the condensed consolidated financial statements herein.

## Market risk

As filed, 304 characters.

There have been no other material changes in our market risk exposure during the three months ended December 31, 2023. For a discussion of our exposure to market risk, refer to Part II Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” contained in our 2023 Annual Report on Form 10-K.

## Controls and procedures

As filed, 3,267 characters.

### Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), pursuant to Exchange Act Rule 13a-15 as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2023 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

### Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) or 15d-15(d) that occurred during the three months ended December 31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

### Limitations on Effectiveness of Controls and Procedures

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls also can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks that internal controls may become inadequate as a result of changes in conditions, or through the deterioration of the degree of compliance with policies or procedures.

## Risk factors

As filed, 667 characters.

In addition to the other information set forth in this Quarterly Report on Form 10-Q, including the information contained in Part I, Item 3, you should carefully consider the factors discussed in Part I, Item IA of our 2023 Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results. The risks described in this Quarterly Report on Form 10-Q and in our 2023 Annual Report on Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Filed Feb 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001261654-24-000011. Last ingested by Listed: Nov 14, 2026, 12:25 ET. No prices; not investment advice.
